[HTML][HTML] Mucosa-interfacing electronics
The surface mucosa that lines many of our organs houses myriad biometric signals and,
therefore, has great potential as a sensor–tissue interface for high-fidelity and long-term …
therefore, has great potential as a sensor–tissue interface for high-fidelity and long-term …
Multifunctional hydrogels based on chitosan, hyaluronic acid and other biological macromolecules for the treatment of inflammatory bowel disease: A review
Y Ouyang, J Zhao, S Wang - International journal of biological …, 2023 - Elsevier
Hydrogel is a three-dimensional network polymer material rich in water. It is widely used in
the biomedical field because of its unique physical and chemical properties and good …
the biomedical field because of its unique physical and chemical properties and good …
Electrospun Janus core (ethyl cellulose//polyethylene oxide)@ shell (hydroxypropyl methyl cellulose acetate succinate) hybrids for an enhanced colon-targeted …
J Zhou, T Yi, Z Zhang, DG Yu, P Liu, L Wang… - … Composites and Hybrid …, 2023 - Springer
Structural polymeric nanohybrids is presently a popular topic and can be conceived for
numerous functional applications, including the pH-sensitive oral colon-targeted drug …
numerous functional applications, including the pH-sensitive oral colon-targeted drug …
Oral polyphenol-armored nanomedicine for targeted modulation of gut microbiota–brain interactions in colitis
Developing oral nanomedicines that suppress intestinal inflammation while modulating gut
microbiota and brain interactions is essential for effectively treating inflammatory bowel …
microbiota and brain interactions is essential for effectively treating inflammatory bowel …
[HTML][HTML] Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment
Y Huang, X Guo, Y Wu, X Chen, L Feng, N Xie… - … and Targeted Therapy, 2024 - nature.com
Inflammation-associated diseases encompass a range of infectious diseases and non-
infectious inflammatory diseases, which continuously pose one of the most serious threats to …
infectious inflammatory diseases, which continuously pose one of the most serious threats to …
[HTML][HTML] Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
DA Subramanian, R Langer, G Traverso - Journal of nanobiotechnology, 2022 - Springer
Oral delivery of therapeutics is the preferred route of administration due to ease of
administration which is associated with greater patient medication adherence. One major …
administration which is associated with greater patient medication adherence. One major …
[HTML][HTML] Immunotoxicity responses to polystyrene nanoplastics and their related mechanisms in the liver of zebrafish (Danio rerio) larvae
H Cheng, Z Duan, Y Wu, Y Wang, H Zhang, Y Shi… - Environment …, 2022 - Elsevier
Nanoplastics in aquatic environments may induce adverse immunotoxicity effects in fish.
However, there is insufficient evidence on the visible immunotoxicity endpoints in the larval …
However, there is insufficient evidence on the visible immunotoxicity endpoints in the larval …
Reactive Oxygen Species‐Activated CO Versatile Nanomedicine with Innate Gut Immune and Microbiome Remodeling Effects for Treating Inflammatory Bowel …
Y Zeng, M Fan, Q Zhou, D Chen, T Jin… - Advanced Functional …, 2023 - Wiley Online Library
Abnormal activation of the gut mucosal immune system and a highly dysregulated gut
microbiota play essential roles in the progression of inflammatory bowel disease (IBD). The …
microbiota play essential roles in the progression of inflammatory bowel disease (IBD). The …
Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease
Y Pu, X Fan, Z Zhang, Z Guo, Q Pan, W Gao… - Journal of Controlled …, 2023 - Elsevier
The inflammatory bowel disease (IBD) is incurable, chronic, recrudescent disorders in the
inflamed intestines. Current clinic treatments are challenged by systemic exposure-induced …
inflamed intestines. Current clinic treatments are challenged by systemic exposure-induced …
Nanoprobiotics for remolding the pro-inflammatory microenvironment and microbiome in the treatment of colitis
J Li, M Sun, L Liu, W Yang, A Sun, J Yu, D Liu… - Nano Letters, 2023 - ACS Publications
Despite the great progress of current bacterially based biotherapeutics, their unsatisfying
efficacy and underlying safety problems have limited their clinical application. Herein …
efficacy and underlying safety problems have limited their clinical application. Herein …